{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T23:27:20Z","timestamp":1780702040072,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1016647"],"award-info":[{"award-number":["1016647"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1023407"],"award-info":[{"award-number":["1023407"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1073284"],"award-info":[{"award-number":["1073284"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009809","name":"John T. Reid Charitable Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.semarthrit.2016.09.009","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T10:25:45Z","timestamp":1475231145000},"page":"804-809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case\u2013control study"],"prefix":"10.1016","volume":"46","author":[{"given":"Susan","family":"Tadros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Teichtahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Ciciriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian P.","family":"Wicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2016.09.009_bib1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semarthrit.2015.01.007","article-title":"Pneumocystis jirovecci pneumonia in connective tissue diseases: comparison with other immunocompromised patients","volume":"45","author":"Teichtahl","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1378\/chest.118.3.704","article-title":"Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib4","unstructured":"CDC guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents; Nov 2015."},{"key":"10.1016\/j.semarthrit.2016.09.009_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199001183220304","article-title":"The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1","volume":"322","author":"Phair","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/515658","article-title":"Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis","volume":"178","author":"Kaplan","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3899\/jrheum.090843","article-title":"A survey of rheumatologists\u02bc practice for prescribing pneumocystis prophylaxis","volume":"37","author":"Cettomai","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib8","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archinte.1995.00430110015002","article-title":"Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome","volume":"155","author":"Sepkowitz","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/acr.21857","article-title":"Recent-onset systemic lupus erythematosus complicated by acute respiratory failure","volume":"65","author":"Demoruelle","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib10","first-page":"246","article-title":"Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases","volume":"21","author":"Godeau","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib11","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/archinte.1997.00440340145015","article-title":"Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis","volume":"157","author":"Bachelez","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.rhu.0000221794.24431.36","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue disease","volume":"12","author":"Li","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00365540601150497","article-title":"Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002\u20132004","volume":"39","author":"Overgaard","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199503163321101","article-title":"A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection","volume":"332","author":"Bozzette","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00042560-199706010-00002","article-title":"Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients","volume":"15","author":"Bucher","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjc.6602412","article-title":"An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital","volume":"92","author":"Worth","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/ejh.12135","article-title":"Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis","volume":"91","author":"Haeusler","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jmii.2010.08.006","article-title":"Mortality predictors of Pneumocystis jirovecii pneumonia in human immunodeficiency virus-infected patients at presentation: experience in a tertiary care hospital of northern Taiwan","volume":"44","author":"Wang","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1469-0691.2010.03143.x","article-title":"Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case\u2013control study","volume":"16","author":"De Castro","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-80-1-83","article-title":"Pneumocystis carinii pneumonia in the United States","volume":"80","author":"Walzer","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/QAD.0b013e32835e2c90","article-title":"Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors?","volume":"27","author":"Schoffelen","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1469-0691.2004.00921.x","article-title":"Epidemiology of Pneumocystis carinii pneumonia in southern Spain","volume":"10","author":"Calderon","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1469-0691.2004.00937.x","article-title":"Climatic factors and Pneumocystis jiroveci infection in southern Spain","volume":"10","author":"Varela","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/pmj.79.929.164","article-title":"Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia","volume":"79","author":"Lubis","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib26","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/0140-6736(92)90789-6","article-title":"Seasonal incidence of Pneumocystis carinii pneumonia","volume":"339","author":"Vanhems","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1469-0691.2009.02804.x","article-title":"Seasonal variation of Pneumocystis jirovecii infection: analysis of underlying climatic factors","volume":"15","author":"Sing","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib28","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib29","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib30","first-page":"792","article-title":"Association or causation: evaluating links between \u201cenvironment and disease\u201d","volume":"83","author":"Lucas","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib31","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/ar4472","article-title":"Prophylaxis for pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study","volume":"16","author":"Katsuyama","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.11150\/kansenshogakuzasshi1970.73.1123","article-title":"Efficacy of sulfamethoxazole-trimethoprim administration in the prevention of Pneumocystis carinii pneumonia in patients with connective tissue disease","volume":"73","author":"Okada","year":"1999","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/PL00021707","article-title":"Prediction of and prophylaxis against pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy","volume":"15","author":"Ogawa","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib34","series-title":"Clinical guideline: the Japanese Ministry of Health, Laboratory and Welfare Study Group on complications and treatment of immune disease","first-page":"24","article-title":"Prophylaxis of Pneumocystis jirovecii pneumonia associated with inflammatory rheumatic disease","author":"Inokuma","year":"2004"},{"key":"10.1016\/j.semarthrit.2016.09.009_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2334-4-42","article-title":"Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention","volume":"4","author":"Sowden","year":"2004","journal-title":"BMC Infect Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721630302X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721630302X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:22:57Z","timestamp":1777472577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901721630302X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S004901721630302X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.09.009","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}